Skip to main content
logo
Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China flag China · Delayed Price · Currency is CNY
18.80
+1.06 (5.98%)
At close: Mar 19, 2026

SHE:002082 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
10,8518,5213,9333,9155,4099,082
Market Cap Growth
199.16%116.64%0.47%-27.62%-40.45%7.23%
Enterprise Value
11,7759,4454,8994,8255,8709,910
Last Close Price
17.7413.936.436.288.5114.27
PE Ratio
--70.9479.5658.0054.55
Forward PE
-6.446.446.446.446.44
PS Ratio
9.487.442.732.543.034.70
PB Ratio
3.923.081.431.421.923.31
P/TBV Ratio
5.194.071.891.852.544.53
P/FCF Ratio
--170.18---
P/OCF Ratio
--32.72--411.24
EV/Sales Ratio
10.298.253.393.133.295.13
EV/EBITDA Ratio
--28.7529.4217.4032.48
EV/EBIT Ratio
--65.5268.7425.2447.04
EV/FCF Ratio
--211.95---
Debt / Equity Ratio
0.330.330.370.350.310.31
Debt / EBITDA Ratio
--5.935.842.552.76
Debt / FCF Ratio
--44.49---
Net Debt / Equity Ratio
0.300.300.310.270.14-0.02
Net Debt / EBITDA Ratio
-10.85-10.855.044.571.18-0.23
Net Debt / FCF Ratio
--37.14-3.72-0.970.26
Asset Turnover
--0.340.360.420.39
Inventory Turnover
--3.613.413.131.80
Quick Ratio
--0.931.091.571.63
Current Ratio
--1.371.451.941.92
Return on Equity (ROE)
-7.20%-7.20%1.64%0.94%2.65%5.75%
Return on Assets (ROA)
--1.08%1.03%3.38%2.63%
Return on Invested Capital (ROIC)
-4.79%-4.78%1.61%1.84%5.81%2.75%
Return on Capital Employed (ROCE)
--2.50%2.40%7.50%6.80%
Earnings Yield
-1.83%-2.33%1.41%1.26%1.72%1.83%
FCF Yield
--0.59%-5.15%-7.52%-2.90%
Dividend Yield
---1.27%1.41%-
Payout Ratio
--163.85%247.98%47.08%115.10%
Buyback Yield / Dilution
-0.84%-0.84%-0.15%1.06%-0.82%-1.73%
Total Shareholder Return
-0.84%-0.84%-0.15%2.34%0.59%-1.73%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.